Tissue and host tropism of influenza viruses: Importance of quantitative analysis

Size: px
Start display at page:

Download "Tissue and host tropism of influenza viruses: Importance of quantitative analysis"

Transcription

1 Science in China Series C: Life Sciences 2009 SCIENCE IN CHINA PRESS Review life.scichina.com Tissue and host tropism of influenza viruses: Importance of quantitative analysis ZHANG Hong 1,2 1 Z-BioMed, Inc., Rockville, MD 20855, USA; 2 Department of Respiratory Medicine, Affiliated Hospital of Zunyi Medical College, Zunyi , China It is generally accepted that human influenza viruses preferentially bind to cell-surface glycoproteins/ glycolipids containing sialic acids in α2,6-linkage; while avian and equine influenza viruses preferentially bind to those containing sialic acids in α2,3-linkage. Even though this generalized view is accurate for H3 subtype isolates, it may not be accurate and absolute for all subtypes of influenza A viruses and, therefore, needs to be reevaluated carefully and realistically. Some of the studies published in major scientific journals on the subject of tissue tropism of influenza viruses are inconsistent and caused confusion in the scientific community. One of the reasons for the inconsistency is that most studies were quantitative descriptions of sialic acid receptor distributions based on lectin or influenza virus immunohistochemistry results with limited numbers of stained cells. In addition, recent studies indicate that α2,3- and α2,6-linked sialic acids are not the sole receptors determining tissue and host tropism of influenza viruses. In fact, determinants for tissue and host tropism of human, avian and animal influenza viruses are more complex than what has been generally accepted. Other factors, such as glycan topology, concentration of invading viruses, local density of receptors, lipid raft microdomains, coreceptors or sialic acid-independent receptors, may also be important. To more efficiently control the global spread of pandemic influenza such as the current circulating influenza A H1N1, it is crucial to clarify the determinants for tissue and host tropism of influenza viruses through quantitative analysis of experimental results. In this review, I will comment on some conflicting issues related to tissue and host tropism of influenza viruses, discuss the importance of quantitative analysis of lectin and influenza virus immunohistochemistry results and point out directions for future studies in this area, which should lead to a better understanding of tissue and host tropism of influenza viruses. tissue and host tropism, influenza viruses, sialic acid receptors, quantitative analysis The influenza viruses belong to the Orthomyxoviridae family and are enveloped animal viruses containing a segmented single-stranded RNA genome [1,2]. They are classified into three types, A, B and C, based on their immunologically distinct nucleoprotein and matrix protein antigens. Type A influenza viruses are further grouped into antigenic subtypes according to their specific surface glycoproteins hemagglutinin (HA) and neuraminidase (NA). Influenza A occurs in humans, other mammals, and birds and sixteen distinct HA subtypes and nine NA subtypes are currently recognized. Influenza A attracts the most attention because it is associated with high morbidity and mortality in people of all ages, caused millions of deaths in the previous three influenza pandemics, is the cause of the current influenza H1N1 pandemic and has the potential to cause more pandemics in the future [3,4]. A new human influenza virus could initiate as an avian or animal influenza virus that adapts to humans through accumulation of mutations or as a hybrid influ- Received October 1, 2009; accepted November 11, 2009 doi: /s x Corresponding author ( hzhang@zbiomed.com ) Citation: ZHANG Hong. Tissue and host tropism of influenza viruses: Importance of quantitative analysis. Sci China Ser C-Life Sci, 2009, 52(12): , doi: /s x

2 enza virus containing a combination of genes derived from an avian, an animal and a human influenza virus. Therefore, influenza pandemics arise when a new influenza virus emerges from human, avian or animal influenza viruses or from reassortants of them, infects humans, and spreads efficiently among people. The first transmission of the highly pathogenic H5N1 avian influenza A virus directly from chickens to humans in Hong Kong was reported in 1997 [5]. As of 31 August 2009, a total of 440 laboratory-confirmed human cases of avian influenza A (H5N1) virus infections from 15 countries have been reported to WHO and 262 of them (59.5%) have been fatal ( In China, 25 of the 38 confirmed cases (65.8%) have been fatal. Among the 45 confirmed cases (12 deaths) reported to WHO in 2009, 7 were from China and 4 of them were fatal. These events demonstrate that avian influenza viruses can infect human directly and China is an important country for the surveillance, prevention and control of potential influenza pandemics. Continued circulation of H5N1 and other avian influenza viruses in Asia shows that a future pandemic from avian influenza is a real threat. The current circulating influenza A H1N1 viruses were probably originated from the combination of six gene segments (PB2, PB1, PA, HA, NP, and NS1) from swine influenza H1N2 viruses circulating in the USA from 1999 to 2001 (nucleotide sequence similarities >96%) and two gene segments (NA and M1) from swine influenza viruses circulating in Europe from 1985 to 1999 (nucleotide sequence similarities >93%) [6]. The gene segments of these influenza A H1N1 viruses could also be traced back to human or avian origins if those nucleotide sequences with similarities lower than 93% were considered. Since the first report of the swine influenza H1N1 in April 2009 [7], there have been over cases and at least 6770 deaths (1.29%) reported to the WHO from all regions of the world (www. who. int). The WHO Director-General raised the level of influenza pandemic alert from phase 5 to phase 6 on June 11, 2009 following the advice from the Emergency Committee which concluded that the criteria for a pandemic had been met. Currently, pandemic H1N1 influenza virus continues to be the predominant circulating virus of influenza in the world and all pandemic H1N influenza viruses sequenced so far have been antigenically and genetically very similar to the first sequenced new influenza virus (A/California/7/2009). At this stage, the influenza H1N1 pandemic can still be characterized as being moderate in terms of severity and mortality rate. The epidemiology, molecular biology, pathology, and pathogenic factors of influenza viruses including H5N1 in humans have been comprehensively reviewed recently [8 14]. This article will briefly review the generalized view of receptors for influenza viruses, comment on some conflicting issues related to tissue and host tropism of influenza viruses, discuss the importance of quantitative analysis of lectin and influenza virus immunohistochemistry results and point out directions for future studies in this area. 1 Generalized view of receptors for influenza viruses The generalized view is that avian influenza viruses replicate in the gastrointestinal tract of the host and preferentially bind to cell-surface glycoproteins or glycolipids containing sialic acids in α2,3-linkage (SAα2,3); while human influenza viruses replicate in the host s respiratory tract and bind to respiratory epithelial cells via sialic acids attached to glycoproteins or glycolipids containing sialic acids in α2,6-linkage (SAα2,6). Hundreds of articles including many reviews related to influenza virus receptors have been published during last 20 years. Many review articles and several articles published in major scientific journals such as Science, Nature and Nature Medicine made generalized statements about influenza virus receptors and cited two original articles published in 1983 [15,16]. Here are some examples: Human and avian influenza A viruses differ in their recognition of host cell receptors: the former preferentially recognize receptors with saccharides terminating in sialic acid-α2,6-galactose (SAα2,6Gal), whereas the latter prefer those ending in SAα2,3Gal [17] ; Avian influenza viruses bind to cell-surface glycoproteins or glycolipids containing terminal sialyl-galactosyl residues linked by 2-3-linkages [Neu5Ac(α2-3)Gal], whereas human viruses, including the earliest available isolates from 1957 and 1968 pandemics, bind to receptors that contain terminal 2-6-linked sialyl-galactosyl moieties [Neu5Ac(α2-6)Gal] [18] ; HA binds to receptors containing glycans with terminal sialic acids, where their precise linkage determines species preference. A switch in receptor specificity from sialic acids connected to galactose in α2-3 linkages (avian) to α2-6 linkages (human) is a major obstacle for influenza A viruses to 1102 ZHANG H. Sci China Ser C-Life Sci Dec vol. 52 no

3 cross the species barrier and to adapt to a new host [19] ; Human viruses of the H1, H2 and H3 subtypes that are known to have caused pandemics in 1918, 1957, and 1968, respectively, recognize α2,6-linked sialic acid [20] ; and Human influenza strains preferentially bind to sialic acid residues linked to galactose by the α2,6 linkage, while avian and equine influenza strains recognize sialic acid linked to galactose by α2,3 linkage. [21] In one of their original articles published in 1983, Rogers et al. [15] modified human type B erythrocytes to contain sialyloligosaccharides of defined sequence with different sialyltransferases purified from porcine submaxillary glands and rat liver, and examined differential adsorption of influenza virus strains isolated from a variety of hosts. Hemagglutination results of human and animal strains (Table 1 of the article by Rogers et al. [15] ) indicated that receptor determinants of human (SAα2,6Gal) and avian (SAα2,3Gal) influenza virus isolates were accurate only for H3 subtype influenza A viruses [15 ]. In contrast, subtype H2 human strain (A/Japan/305/57) showed the same HA titers (1024) for both SAα2,6Gal and SAα2,3Gal receptors; subtype H1 human strains A/PR/8/34 and A/FM/1/47 preferentially bound to avian specific receptor SAα2, 3Gal (HA titers of 256 and 512) instead of human specific receptor SAα2,6Gal (HA titers of 128 and 256); and subtype H1 avian strain (A/duck/Alberta/513/78) bound to both human and avian receptors (HA titers of 512 for SAα2,6Gal and 1024 for SAα2,3Gal). Therefore, their results with H1 and H2 subtype influenza viruses were contradictory to those with H3 subtype influenza viruses and did not support the generalized view of influenza virus receptor specificities for either human (SAα2,6Gal) or avian (SAα2,3Gal) receptors. Rogers et al. were probably aware of their contradictory results of H1 and H2 subtypes at the time and cautiously concluded in the abstract of the article Receptor specificity appeared, to some extent, to be dependent on the species from which the virus was isolated. In particular, human isolates of the H3 serotype all agglutinated cells containing the SAα2,6Gal linkage, but not cells bearing the SAα2,3Galβ1,3GalNAc sequence. In contrast, antigenically similar (H3) isolates from avian and equine species preferentially bound erythrocytes containing the SAα2,3Gal linkage [15]. It is unclear how Receptor specificity appeared, to some extent, to be dependent on the species (true for H3 subtype isolates only) could have evolved to become generalized statements such as human influenza viruses preferentially recognize receptors with SAα2,6Gal, whereas avian influenza viruses preferentially recognize receptors with SAα2,3Gal (implying isolates of all HA subtypes). In another article of Rogers et al., the sequencing bands showing mutations of CTG-leucine (human specific) to CAG-glutamine (avian specific) or ATG-methionine (specific for both human and avian receptors) at amino acid 226 of HA1 were not clear enough to make definitive conclusions [16]. In conclusion, the generalized view that avian and human influenza viruses preferentially bind to cell-surface glycoproteins or glycolipids containing sialic acids in α2,3-linkage and α2,6-linkage respectively may not be accurate and absolute for all subtypes of influenza A viruses, and therefore, would need to be reevaluated carefully and realistically with quantitative analysis of more experimental results. 2 Distribution of sialic acid receptors and cell/tissue tropism of influenza viruses Lectins such as Sambucus nigra agglutinin (SNA) and Maackia amurensis agglutinin (MAA) have been used to measure the distribution of SAα2,3Gal or SAα2,6 terminated glycoprotein or glycolipids in tissue sections by immunohistochemistry methods. Labeled influenza viruses have also been used to determine the cell and tissue tropism of human, avian and animal influenza viruses. To illustrate that some of the studies published in major scientific journals are inconsistent and caused confusion on the subject of cell and tissue distribution of SAα2,3 and SAα2,6 receptors as well as tropism of influenza viruses, those related studies have been compared and summarized in the Table 1. Matrosovich et al. demonstrated in 2004 that human and avian influenza viruses target different cell types in cultures of human airway epithelium: human influenza viruses preferentially infected non-ciliated cells, while avian influenza viruses mainly infected ciliated cells [18]. They found that tropism for a specific type of airway epithelial cells depends on the virus host species, rather than on virus type, subtype, or strain and this pattern correlated with the predominant localization of human influenza receptors (α2-6-linked sialic acids) on non-ciliated cells and avian influenza receptors (α2-3-linked ZHANG H. Sci China Ser C-Life Sci Dec vol. 52 no

4 Table 1 Summary of recently published studies on the subject of tissue distribution of SAα-2,3 and SAα-2,6 receptors and in6fection of human tissues with influenza viruses Published Studies PNAS 2004 [18] Nature 2006 [22] Science 2006 [23] Respir Res 2007 [24] FASEB J 2008 [25] Distribution of SAα-2,3 and SAα-2,6 Receptors In Tissues ΜΑΑ Binding for SAα-2,3Gal receptor (avian) Nasal/ pharynx Trachea/ bronchus Lung aveolus Bound to some ciliated primary epithelial cells Bound to some ciliated primary epithelial cells Occasionally detected on epithelial cells in nasal mucosa Found on non-ciliated cuboidal bronchiolar cells at the junction between bronchiole and alveolus Found on cells lining the alveolar wall Strong MMA1 binding but no MMA2 binding in the epithelium MAA1 bound to bronchial cells; Strong MMA binding but no MMA2 binding to ciliated and nonciliated cells MAA1 bound to alveolar macrophages but not pneumocytes; Detected on a small proportion of non-ciliated and a few ciliated epithelial cells Detected on non-ciliated and a few ciliated epithelial cells and endothelial cells (EC) Detected on type II cells and endothelial cells MAA2 bound to pneumocytes Other tissues Detected on brain neuron and EC; placenta EC; liver Kupffer cells; kidney glomerular EC; heart EC; intestines neurons and EC; and T cells in spleen SΝΑ Binding for SAα-2,6Gal receptor (human) Nasal/ pharynx Trachea/ bronchus Strong staining on non-ciliated primary epithelial cells Strong staining on nonciliated primary epithelial cells Dominant on epithelial cells in nasal mucosa Found on trachea and bronchus epithelia cells Strong binding of SNA in the epithelium Strong binding of SNA in ciliated and non-ciliated cells Detected on ciliated and non-ciliated epithelial cells and EC Detected on ciliated and nonciliated epithelial cells and EC Lung/aveolus Found on alveolar cells Minimal SNA binding Detected on pneumocytes and EC Other tissues Detected on brain EC; placenta Hofbauer cells and EC; liver bile duct epithelial cells and EC; kidney glomerular EC and distal tubule epithelial cells; heart EC; intestines EC; and B cells in spleen (to be continued on the next page)

5 (Continued) Tissues Infected by Influenza Viruses Human viruses Preferentially infected nonciliated cells Human A/Kawasaki/173/01 (H1N1) bound extensively to epithelial cells in the bronchi and, to a lesser degree, to alveolar cells; H5N1 virus (A/Hong Kong/213/03) infected both alveolar cells and bronchial epithelial cells Human A/Netherlands/213/03 (H3N2) bound to epithelial cells in trachea Avian viruses Mainly infected ciliated cells Avian A/duck/Mongolia/301/01 (H3N2) and A/duck/Vietnam/5001/05 (H5N1) viruses didn t infect bronchial epithelial cells; but they bound extensively to alveolar cells; A/duck/Vietnam/5001/05 did infect alveolar cells H5N1 virus (A/Vietnam/1194/04) attached predominantly to type II pneumocytes, alveolar macrophages, and nonciliated cuboidal epithelial cells in terminal bronchioles ; Attachment became progressively rarer toward the trachea Conclusions 1. The predominant localization of human receptors (SAα2,6) localized predominantly on non-ciliated epithelial cells; 2. Avian receptors (SAα2,3) localized predominantly on ciliated epithelial cells; 3. Ciliated cells most likely serve as primary target cells in cases where avian viruses cause human disease. 1. Avian and human flu viruses seem to target different regions of a patient s respiratory tract ; 2. Although not quantitative, these results indicate that there could be functional significance in the preferential expression of SAα2,3Gal and SAα2,6Gal molecules on human airway cells ; 3. Findings indicate that H5N1 viruses can replicate efficiently only in cells in the lower region of the respiratory tract. 1. The findings fit with the limited pathology data for H5N1 virus infection in humans ; 2. The findings contrast with the idea that avian influenza viruses generally have little affinity for human respiratory tissues ; 3. The predilection of H5N1 virus for type II pneumocytes and alveolar macrophages may contribute to the severity of the pulmonary lesion. 1. MAA binding pattern may be dependent on the supplier and different isoforms show a different tissue distribution; 2. Identified a heterogeneous distribution of SNA and MAA binding in bronchial epithelium with no clear distinction between ciliated and non-ciliated cells; 3. SNA binding was widespread in the upper than the lower respiratory tract. 1. HuIV-Rs were abundantly present in the respiratory tract and lungs. They were also detected on Hofbauer cells, glomerular cells, splenic B cells, and in the liver ; 2. Endothelial cells of all organs examined expressed both human and avian receptors; 3. The distribution pattern of AIV-Rs is partially inconsistent with the pattern of infected cells as detected in previous studies, which suggests there may be other receptors or mechanisms involved in H5N1 infection. SNA, a lectin from the elderberry plant Sambucus nigra agglutinin; MAA, Maackia amurensis agglutinin; EC, endothelial cells.

6 sialic acids) on ciliated cells. Based on quantitative analysis of immunostaining of influenza virus-infected cells, Matrosovich et al. concluded that ciliated cells most likely serve as primary target cells in those rare cases where avian viruses cause human disease [18]. In contrast, Shinya et al. reported in their 2006 article that α2-3-linked sialic acids (avian influenza receptors) were found on non-ciliated cuboidal bronchiolar cells and α2-6-linked sialic acids (human influenza receptors) were dominant on epithelial cells in nasal mucosa, with α2-3-linked sialic acids being occasionally detected [22]. However, a substantial number of cells lining the alveolar wall also expressed α2-3-linked sialic acids. Shinya et al. observed that human-derived viruses (such as A/Kawasaki/173/01) bound extensively to epithelial cells in the bronchi and, to a lesser degree, to alveolar cells (3 stained cells shown in Figure 2b of the article); by contrast, avian viruses (such as A/duck/ Mongolia/301/ 01) bound extensively to alveolar cells (8 stained cells shown in Figure 2d) but less widely to bronchial epithelial cells based on qualitative analysis of their immunohistochemical results. They concluded that A/Hong Kong/213/03 virus infected bronchial epithelial cells by showing about 9 stained cells (Supplementary Figure 4c) and alveolar cells by showing about 12 stained cells (Supplementary Figure 4d). Shinya et al. suggested, Although not quantitative, these results indicate that there could be functional significance in the preferential expression of SAα2,3Gal and SAα2,6Gal molecules on human airway cells and Our findings indicate that H5N1 viruses can replicate efficiently only in cells in the lower region of the respiratory tract. [22] In their article published in 2006, van Riel et al. [23] identified the cell types in the lower respiratory tract of humans and four animal species (mouse, ferret, macaque, and cat) to which H5N1 virus (A/Vietnam/1194/04) attached by showing 1 to 3 stained cells in each of the tissue sections using immunohistochemistry technique. They found that H5N1 virus attached mainly to type II pneumocytes, alveolar macrophages, and non-ciliated cuboidal epithelial cells in terminal bronchioles; and attachment became progressively rarer toward the traches. They concluded, These findings fit with the limited pathology data for H5N1 virus infection in humans, which show diffuse alveolar damage and the presence of H5N1 virus antigen in type II pneumocytes. However, they contrast with the idea that avian influenza viruses generally have little affinity for human respiratory tissues. They also suggested The predilection of H5N1 virus for type II pneumocytes and alveolar macrophages may contribute to the severity of the pulmonary lesion. [23] Using Maackia amurensis lectin II (MAL-II, MAA2) and Sambubus nigra agglutinin (SNA), Yao et al. investigated the distribution of α2,3-linked and α2,6-linked sialic acids in various organs including upper and lower respiratory tracts of two H5N1 cases and 14 control cases [24]. They observed that avian influenza receptors (α2,3-linked sialic acids) were detected on different cells including type II pneumocytes, a limited number of epithelial cells of the upper respiratory tract, the bronchi, bronchioli, and trachea, splenic T cells, and neurons in the brain and intestines. They suggested, the relative lack of AIV-Rs in the upper airway may be one of the factors preventing efficient human-to-human transmission of H5N1 influenza [24]. Yao et al. found that human influenza receptors (α2,6-linked sialic acids) were abundantly present in the respiratory tract and lungs and were detected on Hofbauer cells, glomerular cells, splenic B cells, and in the liver. Yao et al. also found that endothelial cells of all organs examined expressed both avian and human receptor types which may account for the multiple organ involvement in H5N1 influenza [24]. In their 2007 article, Nicholls et al. compared the lectin binding properties of MAA from different suppliers and found that there were differences in tissue distribution of the α2,3 linked SA when 2 different isomers of MAA (MAA1 for SAα2,3Galb1,4GlcNac and MAA2 for SAα2,3Galb1,3GlcNac) lectin were used. MAA1 had widespread binding throughout the upper and lower respiratory tract. By comparison, MAA2 binding was mainly restricted to the alveolar epithelial cells of the lung [25]. They suggested in the article We also urge attention to the exact isoform of MAA present in lectins supplied by different manufacturers. These results imply a need for a re-evaluation of the findings reported in previous studies on the tissue distribution of SA receptor types. They also mentioned, Since MAA1 bound to non-saα2,3 glycans it has not been used as extensively by some researchers as MAA2. For instance, Shinya et al. have recently demonstrated SAα2,3Gal expression only in the lung but not the bronchus or 1106 ZHANG H. Sci China Ser C-Life Sci Dec vol. 52 no

7 upper respiratory tract [7]. Since they only used MAA2 lectin binding (Y. Kawaoka, personal communication) our MAA2 results are in accord with theirs. But our finding of MAA1 binding in the upper and lower respiratory tract does have implications for the possible distribution of receptors for avian influenza viruses including the currently circulating H5N1 viruses. It is clear that results by Shinya et al. SAα2,6Gal is dominant on epithelial cells in nasal mucosa, with SAα2,3Gal being occasionally detected [22] and their conclusion Our findings may provide a rational explanation for why H5N1 viruses at present rarely infect and spread between humans although they can replicate efficiently in the lungs [22] were incomplete because they only used MAA2. As summarized in Korteweg and Gu s review article, Conflicting results have been reported as to the cell type expressing avian influenza virus receptors in the trachea and bronchi. [8]. Tollis et al. also stated the determinants involved in host range restriction have not been completely clarified The H5N1 viruses isolated from human in Hong Kong were shown to retain the receptor binding properties of avian viruses, thus suggesting that gene products other than HA may contribute to host range restriction [12]. The summarized results of recently published studies on the subject of cell and tissue distribution of SAα2,3 and SAα2,6 receptors and tissue tropism of influenza viruses show the inconsistency of these studies, because some of the studies were qualitative descriptions of receptor distributions based on immunohistochemistry results with limited numbers of stained cells and without common standard controls (Table 1). To make published results repeatable and comparable among different laboratories, immunohistochemistry results should be analyzed quantitatively. 3 Alpha 2-3 and alpha 2-6 linked sialic acids are not the sole receptors determining cell and host tropism for influenza viruses More than 750 articles related to influenza virus receptors have been published during last 10 years and attention has primarily been given to the role of alpha 2-3 and alpha 2-6 linked sialic acids as receptors of human, avian and animal influenza viruses. However, conflicting results have been reported in major scientific journals on the subject of the cell and tissue distribution of influenza virus receptors (Table 1) [18,22 26]. As Yao et al. concluded after investigating the expression of avian (AIV-Rs) and human influenza receptors (HuIV-Rs) in various organs (upper and lower respiratory tracts, brain, kidney and intestines, etc.) of two H5N1 cases and control cases, the distribution pattern of AIV-Rs is partially inconsistent with the pattern of infected cells as detected in previous studies, which suggests there may be other receptors or mechanisms involved in H5N1 infection and The absence of AIV-Rs in several cell types, including ciliated epithelial cells of the trachea, intestinal epithelial cells, cytotrophoblasts, and Hofbauer cells appears to be in contrast with the detected H5N1-infection of these cells. This suggests that other receptors or coreceptors might be involved in virustarget-cell interaction in H5N1 avian influenza [25]. They also mentioned that It is remarkable, however, that despite the widespread and abundant expression of AIV-Rs in the lungs, only a limited number of pneumocytes have been found to be infected in previous studies, implying that the presence of AIV-Rs is not the only factor affecting the capability of AIV to infect cells. [25] Recent studies published by other groups also indicate that α2,3- and α2,6-linked sialic acids are not the sole receptors determining tissue tropism of influenza viruses [26 32]. The recent article by Nicholls et al. demonstrated that ex vivo cultures of human nasopharyngeal, adenoid and tonsillar tissues can be infected with H5N1 viruses in spite of an apparent lack of sialic acid α2-3 virus receptors [26]. Previous studies by other groups using MDCK cells [27] and human airway tracheobronchial epithelial cells [28] have shown that removal of sialic acid from cultured cells by broad-spectrum sialidases does not abolish infection by human influenza viruses. Using human A549 and Hela cells with high levels of α2-6 sialic acid and CHO cells that have only α2-3 sialic acid, Kumari et al. found that absence of α2-6 sialic acid does not protect a cell from influenza infection and the presence of high levels of α2-6 SA on a cell surface does not guarantee productive replication of a virus with α2-6 receptor specificity [29]. Binding studies of influenza viruses to sialic acids show that reassortant viruses with A/NWS/33 HA bind to α2,8-linked sialic acid [30]. In addition, Glaser et al. [31] have demonstrated that human influenza viruses can infect knock-out mice lacking a major α2,6 sialyltransferase and grow to ZHANG H. Sci China Ser C-Life Sci Dec vol. 52 no

8 similar titers in the lung and trachea as compared to wild-type mice. Results from these studies indicate that α2-3 and α2-6 linked sialic acids are not the sole receptors determining cell and host tropism of influenza viruses and suggest that the absence of these receptors does not necessarily mean cells are protected from infection by influenza viruses automatically. Therefore, it is over simplified to assume that removal of sialic acid receptors from human respiratory tracts would eliminate infections by H5N1, H1N1 and other influenza viruses [33]. Other factors, such as glycan topology [34], local density of receptors, concentration of invading viruses, lipid raft microdomains [35,36], coreceptors or sialic acid-independent receptors, may also be important. In light of the findings discussed above, more attention should be given to other cell surface components in the human respiratory tract important for interactions with avian, swine and human influenza viruses, which will lead to a better understanding of cell and host tropism of influenza viruses and provide new targets for more effective prevention and treatment of seasonal and pandemic influenza. 4 Quantitative analysis of cell and tissue tropism of influenza viruses Three of the articles published in major scientific journals were selected as examples to illustrate why it is important to quantitatively analyze immunohistochemical staining results. In the article published in 2007, Nicholls et al. designed a study to determine the tissue tropism of seven influenza A viruses (one H1N1, one H3N2 and five H5N1) in the upper and lower respiratory tracts [26]. These seven influenza viruses included A/Hong Kong/54/98 (H1N1), A/Hong Kong/1174/99 (H3N2), A/Vietnam/3046/04 (H5N1), A/Hong Kong/483/95 (H5N1), A/Hong Kong/213/03 (H5N1), A/Vietnam/1203/04 (H5N1) and A/Chicken/Indonesia/ BL/03 (H5N1). Nicholls et al. qualitatively reported the cellular location of influenza A nucleoprotein in different tissues and in primary nasopharyngeal cells infected with influenza viruses H1N1, H3N2 and one of the five H5N1 viruses, A/Vietnam/3046/04. These results would be more convincing if the authors had performed a quantitative analysis of the data by scanning more fields under a microscope to count more stained epithelial cells. It would be interesting as well for the scientific community to know whether the other four H5N1 viruses, especially A/Chicken/Indonesia/ BL/03, have the same cellular tropism as that of A/Vietnam/3046/04 [26]. In the same article, the thermal inactivation curve shown in Figure 1e indicated that it took 8 hours to reduce the virus (A/Vietnam/3046/04) titer from 10 4 to % tissue culture infectious doses per ml (TCID 50 / ml). However, as shown in Figure 1h, it took 18 hours to reduce the virus titer from 10 5 to 10 4 TCID 50 /ml for the same influenza virus. If the thermal inactivation curves in Figures 1e and h were switched, then the results of Figure 1e might have not supported the conclusion that productive viral infection in the tissue fragments from the nasopharynx was demonstrated by an increase in the viral yield in culture supernatants (Figure 1e). To show productive viral infection of influenza viruses in primary cultured cells, Gu et al. carried out three independent experiments with each experiment in duplicate [37], therefore, their data could be averaged and expressed as a mean±sd which demonstrated that virus titer was increased continuously from 24 to 48 and 72 hours after infection. In contrast, Nicholls et al. showed decreased virus titers from 20 to 24 hours after infection in Figure 1e and from 24 to 48 hours after infection in Figure 1h using the same virus at the same input dose (10 10 TCID 50 /ml) [26]. It would be helpful if the authors explained why the thermal inactivation curves for the same virus are different between the two experiments and why virus titers did not continuously increase from 20 to 24 hours in Figure 1e and from 24 to 48 hours in Figure 1h after infection. One of the possible explanations is that each experiment was carried out only once and the results may not be reproducible. Furthermore, the authors mislabeled the influenza virus A/Hong Kong/54/98 (H1N1) used in the study as 54/98 (H5N1) in Figure 2d. Nicholls et al. also reported results of lectin histochemistry on the ex vivo biopsies and archival tissues (Supplementary Figure 2), although they realized lectin histochemistry should not be regarded as definitive [26]. There are some concerns regarding their lectin histochemistry studies: (i) Published data are not quantitative; and (ii) the definition of strong positive staining is not given. As described by Matrosovich et al. in their 2004 article [18] and Gu et al. in their 2007 article [37], which quantitatively described immunostaining studies of influenza virus-infected cells, it is feasible to analyze the lectin histochemistry results quantitatively. Matrosovich et al. counted cells by observing en face with 1108 ZHANG H. Sci China Ser C-Life Sci Dec vol. 52 no

9 oil-immersion at 1000 magnification, analyzed fields for each sample, averaged the results and calculated the percentages of specific cells with respect to the total amount of cells. However, Nicholls et al. choose to qualitatively describe their lectin histochemistry results as strong or poor staining instead of quantitatively counting lectin stained/unstained cells and comparing the percentages of lectin stained cells between tissues from the upper and lower respiratory tracts. Without quantitative analysis, it is possible that one group could report the presence of specific receptors by showing 3 or more lectin or virus bound epithelial cells in one tissue section and another group could report the absence of the same receptors by showing 2 or less lectin or virus bound epithelial cells in another tissue section. The above examples have been used to show the importance of quantitative descriptions of sialic acid receptor distributions based immunohistochemistry results. In order to make published results comparable among different laboratories and avoid potential confusion in the field of tissue and host tropism of influenza viruses, every laboratory should analyze lectin and virus immunohistochemistry results quantitatively before reporting in any scientific journals. 5 Conclusion remarks Determinants of tissue and host tropism of human, avian and animal influenza viruses are more complex than what has been generally accepted. Even though the generalized view is accurate for H3 subtype isolates, it may not be accurate and absolute for all subtypes of influenza A viruses based on the analysis of the original results published in 1983 and, therefore, needs to be reevaluated carefully and realistically. Recent published studies indicate that α2-3 and α2-6 linked sialic acids are not the sole receptors determining tissue and host tropism of human and avian influenza viruses [26 32] Other factors, such as glycan topology [34], lipid raft microdomains [35,36], local density of sialic acid receptors, concentration of invading viruses, coreceptors and sialic acid-independent receptors, may also be important in determining tissue and host tropism of human, avian and animal influenza viruses. In light of the findings discussed above, more attention should be given to other cell surface components in the human respiratory tract important for interactions with influenza viruses. Some of the studies published in major scientific journals are inconsistent and caused confusion on the subject of tissue tropism of influenza viruses. To be more effective in controlling the global spread of pandemic influenza such as the current circulating influenza A H1N1, it is crucial to clarify the determinants for tissue and host tropism of influenza viruses through quantitative analysis of experimental results, which should lead to a better understanding of tissue and host tropism of influenza viruses and provide new targets for effective prevention and treatment of seasonal and pandemic influenza. 1 Stephenson I, Nicholson K G. Influenza: vaccination and treatment. Eur Respir J, 2001, 17: [DOI] 2 Nicholson K G, Wood J M, Zambon M. Influenza, Lancet, 2003, 362: [DOI] 3 Laver G, Garman E. Pandemic influenza: Its origin and control. Microbes Infect, 2002, 4: [DOI] 4 Sorrell E M, Ramirez-Nieto G C, Gomez-Osorio I G, et al. Genesis of pandemic influenza. Cytogenet Genome Res, 2007, 117: [DOI] 5 Centers for Disease Control and Prevention (CDC). Isolation of avian influenza A (H5N1) viruses from humans-hong Kong, May- December MMWR Morb Mortal Wkly Rep, 1997, 46: Zhang H, Chen L. Possible origin of current influenza A H1N1 viruses. Lancet Infect Dis, 2009, 9: [DOI] 7 Centers for Disease Control and Prevention (CDC). Swine influenza A (H1N1) infection in two children-southern California, March-April MMWR Morb Mortal Wkly Rep, 2009, 58: Korteweg C, Gu J. Pathology, molecular biology, and pathogenesis of avian influenza A (H5N1) infection in humans. Am J Pathol, 2008, 172: [DOI] 9 Maines T R, Szretter K J, Perrone L, et al. Pathogenesis of emerging avian influenza viruses in mammals and the host innate immune response. Immunol Rev, 2008, 225: 68 84[DOI] 10 Taubenberger J K, Morens D M. The pathology of influenza virus infections. Annu Rev Pathol, 2008, 3: [DOI] 11 Wong S S, Yuen K Y. Avian influenza virus infections in humans. Chest, 2006, 129: [DOI] 12 Tollis M, Di Trani L. Recent developments in avian influenza research: epidemiology and immunoprophylaxis. Vet J, 2002, 164: [DOI] 13 Zambon M C. The pathogenesis of influenza in humans. Rev Med Virol, 2001, 11: [DOI] 14 Subbarao K, Shaw M W. Molecular aspects of avian influenza (H5N1) viruses isolated from humans. Rev Med Virol, 2000, 10: [DOI] 15 Rogers G N, Paulson J C. Receptor determinants of human and animal influenza virus isolates: Differences in receptor specificity of the H3 hemagglutinin based on species of origin. Virology, 1983, 127: ZHANG H. Sci China Ser C-Life Sci Dec vol. 52 no

10 [DOI] 16 Rogers G N, Paulson J C, Daniels R S, et al. Single amino acid substitutions in influenza haemagglutinin change receptor binding specificity. Nature, 1983, 304: 76 78[DOI] 17 Yamada S, Suzuki Y, Suzuki T, et al. Haemagglutinin mutations responsible for the binding of H5N1 influenza A viruses to human-type receptors. Nature, 2006, 444: [DOI] 18 Matrosovich M N, Matrosovich T Y, Gray T, et al. Human and avian influenza viruses target different cell types in cultures of human airway epithelium. Proc Natl Acad Sci USA, 2004, 101: [DOI] 19 Steven J, Blixt O, Tumpey T M, et al. Structure and receptor specificity of the hemagglutinin from an H5N1 influenza virus. Science, 2006, 312: [DOI] 20 Gamblin S J, Haire L F, Russell R J, et al. The structure and receptor binding properties of the 1918 influenza hemagglutinin. Science, 2004, 303: [DOI] 21 de Jong M D, Hien T T. Avian influenza A (H5N1). J Clin Virol, 2006, 35: 2 13[DOI] 22 Shinya K, Ebina M, Yamada S, et al. Avian flu: influenza virus receptors in the human airway. Nature, 2006, 440: [DOI] 23 van Riel D, Munster V J, de Wit E, et al. H5N1 virus attachment to lower respiratory tract. Science, 2006, 312:399[DOI] 24 Nicholls J M, Bourner A J, Chen H, et al. Sialic acid receptor detection in the human respiratory tract: evidence for widespread distribution of potential binding sites for human and avian influenza viruses. Respir Res, 2007, 8: 73[DOI] 25 Yao L, Korteweg C, Hsueh W, et al. Avian influenza receptor expression in H5N1-infected and noninfected human tissues. FASEB J, 2008, 22: [DOI] 26 Nicholls J M, Chan M C, Chan W Y, et al. Tropism of avian influenza A (H5N1) in the upper and lower respiratory tract. Nat Med, 2007, 13: [DOI] 27 Stray S J, Cummings R D, Air G M. Influenza virus infection of desialylated cells. Glycobiology, 2000, 10: [DOI] 28 Thompson C I, Barclay W S, Zambon M C, et al. Infection of human airway epithelium by human and avian strains of influenza a virus. J Virol, 2006, 80: [DOI] 29 Kumari K, Gulati S, Smith D F, et al. Receptor binding specificity of recent human H3N2 influenza viruses. Virol J, 2007, 4: 42[DOI] 30 Wu W, Air G M. Binding of influenza viruses to sialic acids: Reassortant viruses with A/NWS/33 hemagglutinin bind to alpha2,8-linked sialic acid. Virology, 2004, 325: [DOI] 31 Glaser L, Conenello G, Paulson J, et al. Effective replication of human influenza viruses in mice lacking a major alpha2,6 sialyltransferase. Virus Res, 2007, 126: 9 18[DOI] 32 Chu V C, Whittaker G R. Influenza virus entry and infection require host cell N-linked glycoprotein. Proc Natl Acad Sci USA, 2004, 101: [DOI] 33 Zhang H. Concerns of using fusion protein as an experimental drug to combat seasonal and pandemic influenza. J Antimicrob Chemother, 2008, 62: [DOI] 34 Chandrasekaran A, Srinivasan A, Raman R, et al. Glycan topology determines human adaptation of avian H5N1 virus hemagglutinin. Nat Biotechnol, 2008, 26: [DOI] 35 Scheiffele P, Roth M G, Simons K. Interaction of influenza virus haemagglutinin with sphingolipid-cholesterol membrane domains via its transmembrane domain, EMBO J, 1997, 16: [DOI] 36 Takeda M, Leser G P, Russell C J, et al. Influenza virus hemagglutinin concentrates in lipid raft microdomains for efficient viral fusion. Proc Natl Acad Sci USA, 2003, 100: [DOI] 37 Gu J, Xie Z, Gao Z, et al. H5N1 infection of the respiratory tract and beyond: A molecular pathology study. Lancet, 2007, 370: [DOI] 1110 ZHANG H. Sci China Ser C-Life Sci Dec vol. 52 no

Sialic acid and receptor expression on the respiratory tract in normal subjects and H5N1 and non-avian influenza patients

Sialic acid and receptor expression on the respiratory tract in normal subjects and H5N1 and non-avian influenza patients RESEARCH FUND FOR THE CONTROL OF INFECTIOUS DISEASES Key Messages JM Nicholls 黎國思 JSM Peiris 裴偉士 Y Guan 管軼 1. Influenza virus binds to cell receptors via sialic acid (SA) linked glycoproteins. An accurate

More information

Cells and viruses. Human isolates (A/Kawasaki/173/01 [H1N1], A/Yokohama/2057/03 [H3N2],

Cells and viruses. Human isolates (A/Kawasaki/173/01 [H1N1], A/Yokohama/2057/03 [H3N2], Supplementary information Methods Cells and viruses. Human isolates (A/Kawasaki/173/01 [H1N1], A/Yokohama/2057/03 [H3N2], and A/Hong Kong/213/03 [H5N1]) were grown in Madin-Darby canine kidney (MDCK) cells

More information

Differences in influenza virus receptors in chickens and ducks: Implications for interspecies transmission

Differences in influenza virus receptors in chickens and ducks: Implications for interspecies transmission 143 SHORT REPORT Differences in influenza virus receptors in chickens and ducks: Implications for interspecies transmission Suresh V Kuchipudi 1,2, Rahul Nelli 1, Gavin A White 1, Maureen Bain 2, Kin Chow

More information

Influenza Viruses A Review

Influenza Viruses A Review Influenza Viruses A Review AVIAN INFLUENZA: INTERSECTORAL COLLABORATION Larnaca, Cyprus 20 22 July 2009 Kate Glynn Scientific and Technical Department, OIE Influenza Viruses C. Goldsmith,1981 Influenza

More information

Influenza viruses. Virion. Genome. Genes and proteins. Viruses and hosts. Diseases. Distinctive characteristics

Influenza viruses. Virion. Genome. Genes and proteins. Viruses and hosts. Diseases. Distinctive characteristics Influenza viruses Virion Genome Genes and proteins Viruses and hosts Diseases Distinctive characteristics Virion Enveloped particles, quasi-spherical or filamentous Diameter 80-120 nm Envelope is derived

More information

Pandemic Influenza influenza epidemic: realization of a worst-case scenario

Pandemic Influenza influenza epidemic: realization of a worst-case scenario Pandemic Influenza October 9, 2006 1918 influenza epidemic: realization of a worst-case scenario First case: Albert Mitchell, Camp Funston, KS, March 11, 1918 Up to 20% of all humans infected 20-50 million

More information

Risk Assessment of H3N2 Avian Origin Canine Influenza Viruses

Risk Assessment of H3N2 Avian Origin Canine Influenza Viruses Risk Assessment of H3N2 Avian Origin Canine Influenza Viruses Henry Wan, Ph.D. Department of Basic Sciences College of Veterinary Medicine Mississippi State University E-mail: wan@cvm.msstate.edu Phone:

More information

SUPPLEMENTARY INFORMATION

SUPPLEMENTARY INFORMATION SUPPLEMENTARY INFORMATION doi:10.1038/nature10831 1. Pathological analyses of H5 avian-human reassortant viruses. The rgca04 infection in the lungs of ferrets mainly caused severe bronchopneumonia with

More information

Broadly protective influenza vaccines for pandemic preparedness. Suresh Mittal Department of Comparative Pathobiology Purdue University

Broadly protective influenza vaccines for pandemic preparedness. Suresh Mittal Department of Comparative Pathobiology Purdue University Broadly protective influenza vaccines for pandemic preparedness Suresh Mittal Department of Comparative Pathobiology Purdue University Influenza A Virus Orthomyxovirus Consist of s/s (-) sense RNA 8 segments

More information

VIROLOGY OF INFLUENZA. Subtypes: A - Causes outbreak B - Causes outbreaks C - Does not cause outbreaks

VIROLOGY OF INFLUENZA. Subtypes: A - Causes outbreak B - Causes outbreaks C - Does not cause outbreaks INFLUENZA VIROLOGY OF INFLUENZA Subtypes: A - Causes outbreak B - Causes outbreaks C - Does not cause outbreaks PATHOGENICITY High pathogenicity avian influenza (HPAI) Causes severe disease in poultry

More information

Flu, Avian Flu and emerging aspects (H1N1 resistance)

Flu, Avian Flu and emerging aspects (H1N1 resistance) EU-CIS Seminar New trends in Infectious Diseases 26 28 November 2008 / Lyon, France Flu, Avian Flu and emerging aspects (H1N1 resistance) Pr. Florence MORFIN FRE 3011 Université Lyon 1 - CNRS Laboratory

More information

Patricia Fitzgerald-Bocarsly

Patricia Fitzgerald-Bocarsly FLU Patricia Fitzgerald-Bocarsly October 23, 2008 Orthomyxoviruses Orthomyxo virus (ortho = true or correct ) Negative-sense RNA virus (complementary to mrna) Five different genera Influenza A, B, C Thogotovirus

More information

Current Vaccines: Progress & Challenges. Influenza Vaccine what are the challenges?

Current Vaccines: Progress & Challenges. Influenza Vaccine what are the challenges? Current Vaccines: Progress & Challenges Influenza Vaccine what are the challenges? Professor John S. Tam The Hong Kong Polytechnic University Asia-Pacific Alliance for the Control of Influenza (APACI)

More information

Overview of the Influenza Virus

Overview of the Influenza Virus Overview of the Influenza Virus Victor C. Huber, Ph.D. September 24, 2015 victor.huber@usd.edu General Features of Influenza Virus Infections Clinical Features of Influenza Sudden onset of symptoms Incubation

More information

Evolution of influenza

Evolution of influenza Evolution of influenza Today: 1. Global health impact of flu - why should we care? 2. - what are the components of the virus and how do they change? 3. Where does influenza come from? - are there animal

More information

Bioinformation Volume 5

Bioinformation Volume 5 Identification of sequence mutations affecting hemagglutinin specificity to sialic acid receptor in influenza A virus subtypes Usman Sumo Friend Tambunan*, Ramdhan Department of Chemistry, Faculty of Mathematics

More information

دکتر بهروز نقیلی استاد بیماریهای عفونی مرکس تحقیقات بیماریهای عفونی و گرمسیری پاییس 88

دکتر بهروز نقیلی استاد بیماریهای عفونی مرکس تحقیقات بیماریهای عفونی و گرمسیری پاییس 88 دکتر بهروز نقیلی استاد بیماریهای عفونی مرکس تحقیقات بیماریهای عفونی و گرمسیری پاییس 88 FLU.. How often can you escape? Three viral types are distinguished by their matrix and nucleoproteins Type Host Clinical

More information

TITLE: Influenza A (H7N9) virus evolution: Which genetic mutations are antigenically important?

TITLE: Influenza A (H7N9) virus evolution: Which genetic mutations are antigenically important? TITLE: Influenza A (H7N9) virus evolution: Which genetic mutations are antigenically important? AUTHORS: Joshua G. Petrie 1, Adam S. Lauring 2,3 AFFILIATIONS: 1 Department of Epidemiology, University of

More information

Introduction to Avian Influenza

Introduction to Avian Influenza Introduction to Avian Influenza David L. Suarez D.V.M., Ph.D. Research Leader Exotic and Emerging Avian Viral Disease Research Unit Agricultural Research Service United States Department of Agriculture

More information

INFLUENZA-2 Avian Influenza

INFLUENZA-2 Avian Influenza INFLUENZA-2 Avian Influenza VL 7 Dec. 9 th 2013 Mohammed El-Khateeb Overview 1. Background Information 2. Origin/History 3. Brief overview of genome structure 4. Geographical Distribution 5. Pandemic Nature

More information

INFLUENZA VIRUS. INFLUENZA VIRUS CDC WEBSITE

INFLUENZA VIRUS. INFLUENZA VIRUS CDC WEBSITE INFLUENZA VIRUS INFLUENZA VIRUS CDC WEBSITE http://www.cdc.gov/ncidod/diseases/flu/fluinfo.htm 1 THE IMPACT OF INFLUENZA Deaths: PANDEMICS 1918-19 S p a n is h flu 5 0 0,0 0 0 U S 2 0,0 0 0,0 0 0 w o rld

More information

ph1n1 H3N2: A Novel Influenza Virus Reassortment

ph1n1 H3N2: A Novel Influenza Virus Reassortment ph1n1 H3N2: A Novel Influenza Virus Reassortment Jonathan Gubbay Medical Microbiologist Public Health Laboratory Public Health Ontario June 16, 2011 ph1n1 H3N2 Reassortment: Talk Overview Explain strain

More information

Modeling the Antigenic Evolution of Influenza Viruses from Sequences

Modeling the Antigenic Evolution of Influenza Viruses from Sequences Modeling the Antigenic Evolution of Influenza Viruses from Sequences Taijiao Jiang Center of Systems Medicine, Chinese Academy of Medical Sciences Suzhou Institute of Systems Medicine October 8-10, 2015.

More information

Where Health Care Meets Policy. with Dr. Mike Magee

Where Health Care Meets Policy. with Dr. Mike Magee Where Health Care Meets Policy with Dr. Mike Magee The Threat of Bird Flu Understanding Bird Flu and the Influenza Virus 3 types of the influenza virus: A, B and C reflect differences in the M protein

More information

Prevention and treatment of swine-origin influenza virus with interferon: an in vivo and ex vivo study

Prevention and treatment of swine-origin influenza virus with interferon: an in vivo and ex vivo study RESEARCH FUND FOR THE CONTROL OF INFECTIOUS DISEASES Prevention and treatment of swine-origin influenza virus with interferon: an in vivo and ex vivo study JM Nicholls *, RWY Chan, E Fish K e y M e s s

More information

Influenza or flu is a

Influenza or flu is a Clinical and Research Area Infectious Diseases Influenza Virus Types A and B Influenza or flu is a respiratory illness that is caused by influenza viruses. Influenza viruses type A and type B cause seasonal

More information

Influenza: Ecology and Continuing Evolution

Influenza: Ecology and Continuing Evolution Influenza: Ecology and Continuing Evolution Robert G. Webster, PhD Division of Virology Department of Infectious Diseases St. Jude Children s s Research Hospital Influenza Virus Negative sense RNA virus

More information

ORTHOMYXOVIRUSES INFLUENZA VIRUSES. (A,B and C)

ORTHOMYXOVIRUSES INFLUENZA VIRUSES. (A,B and C) ORTHOMYXOVIRUSES INFLUENZA VIRUSES (A,B and C) Orthomyxoviridae Influenza Viruses Epidemiology: Influenza A virus is so subjected to major antigenic changes that cause occasional world wide pandemics when

More information

Lecture 19 Evolution and human health

Lecture 19 Evolution and human health Lecture 19 Evolution and human health The evolution of flu viruses The evolution of flu viruses Google Flu Trends data US data Check out: http://www.google.org/flutrends/ The evolution of flu viruses the

More information

Public health relevant virological features of Influenza A(H7N9) causing human infection in China

Public health relevant virological features of Influenza A(H7N9) causing human infection in China Public health relevant virological features of Influenza A(H7N9) causing human infection in China Address requests about publications of the WHO Regional Office for Europe to: Publications WHO Regional

More information

WHO biosafety risk assessment and guidelines for the production and quality control of human influenza pandemic vaccines: Update

WHO biosafety risk assessment and guidelines for the production and quality control of human influenza pandemic vaccines: Update WHO biosafety risk assessment and guidelines for the production and quality control of human influenza pandemic vaccines: Update 23 July 2009 Introduction This document updates guidance 1 from the World

More information

Detection of Influenza A Virus. THESIS. Presented in Partial Fulfillment of the Requirements for the Degree Master of Science in

Detection of Influenza A Virus. THESIS. Presented in Partial Fulfillment of the Requirements for the Degree Master of Science in Characterization of Sialic Acid Receptors on MDCK Cells Maintained Under Different Media Conditions by Flow Cytometric Analysis and Implications for Detection of Influenza A Virus. THESIS Presented in

More information

Influenza. Gwen Clutario, Terry Chhour, Karen Lee

Influenza. Gwen Clutario, Terry Chhour, Karen Lee Influenza Gwen Clutario, Terry Chhour, Karen Lee Overview Commonly referred to as the flu Defined as a highly contagious viral infection where it starts at the upper respiratory tract and attacks the nose,

More information

Orthomyxoviridae and Paramyxoviridae. Lecture in Microbiology for medical and dental medical students

Orthomyxoviridae and Paramyxoviridae. Lecture in Microbiology for medical and dental medical students Orthomyxoviridae and Paramyxoviridae Lecture in Microbiology for medical and dental medical students Orthomyxoviridae and Paramyxoviridae are ss RNA containng viruses Insert Table 25.1 RNA viruses 2 SIZE

More information

Zoonotic potential of non-avian influenza A viruses

Zoonotic potential of non-avian influenza A viruses Laboratory of Virology Faculty of Veterinary Medicine Ghent University, Belgium Zoonotic potential of non-avian influenza A viruses Prof. Kristien Van Reeth (1) Several documented cases of influenza virus

More information

Influenza: The past, the present, the (future) pandemic

Influenza: The past, the present, the (future) pandemic Influenza: The past, the present, the (future) pandemic Kristin Butler, MLS (ASCP) cm Department of Clinical Laboratory Sciences Louisiana Health Sciences Center - Shreveport Fall 2017 Objectives 1) Detail

More information

Importance of 1918 virus reconstruction on current assessments to pandemic risk

Importance of 1918 virus reconstruction on current assessments to pandemic risk Importance of 1918 virus reconstruction on current assessments to pandemic risk Jessica A Belser, PhD Immunology and Pathogenesis Branch Influenza Division Centers for Disease Control and Prevention National

More information

Influenza. By Allison Canestaro-Garcia. Disease Etiology:

Influenza. By Allison Canestaro-Garcia. Disease Etiology: Influenza By Allison Canestaro-Garcia Disease Etiology: The flu is an infectious disease caused by a subset of viruses of the family Orthomyxoviridae. There are 7 different viruses in this family, four

More information

Influenza and the Poultry Link

Influenza and the Poultry Link Influenza and the Poultry Link Hemagglutinin Neuraminidase Type A Influenza Surface Antigens Subtype Surface Antigens Hemagglutinin 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 human equine swine Neuraminidase

More information

Avian Influenza: Armageddon or Hype? Bryan E. Bledsoe, DO, FACEP The George Washington University Medical Center

Avian Influenza: Armageddon or Hype? Bryan E. Bledsoe, DO, FACEP The George Washington University Medical Center Avian Influenza: Armageddon or Hype? Bryan E. Bledsoe, DO, FACEP The George Washington University Medical Center Definitions: Epidemic The occurrence of cases of an illness in a community or region which

More information

Influenza. Tim Uyeki MD, MPH, MPP, FAAP

Influenza. Tim Uyeki MD, MPH, MPP, FAAP Influenza Tim Uyeki MD, MPH, MPP, FAAP Influenza Division National Center for Immunization and Respiratory Diseases Coordinating Center for Infectious Diseases Centers for Disease Control and Prevention

More information

Cristina Cassetti, Ph.D.

Cristina Cassetti, Ph.D. NIAID Extramural Research Update: Recombinant Influenza Viruses and Biosafety Cristina Cassetti, Ph.D. Influenza Program Officer Division of Microbiology and Infectious Diseases NIAID Influenza virus DMID

More information

Avian Influenza Virus H7N9. Dr. Di Liu Network Information Center Institute of Microbiology Chinese Academy of Sciences

Avian Influenza Virus H7N9. Dr. Di Liu Network Information Center Institute of Microbiology Chinese Academy of Sciences Avian Influenza Virus H7N9 Dr. Di Liu Network Information Center Institute of Microbiology Chinese Academy of Sciences Avian Influenza Virus RNA virus, Orthomyxoviruses Influenza A virus Eight Gene segments

More information

Development of an Influenza Risk Assessment Tool

Development of an Influenza Risk Assessment Tool Development of an Influenza Risk Assessment Tool Susan C. Trock, DVM, MPH, Dip. ACVPM (Epi) Influenza Division, NCIRD, CDC OFFLU Technical Meeting, April 5, 2012 National Center for Immunization & Respiratory

More information

KINETICS OF INFLUENZA A VIRUS INFECTIONS IN A HETEROGENEOUS CELL POPULATION. Marc J. Baron

KINETICS OF INFLUENZA A VIRUS INFECTIONS IN A HETEROGENEOUS CELL POPULATION. Marc J. Baron KINETICS OF INFLUENZA A VIRUS INFECTIONS IN A HETEROGENEOUS CELL POPULATION by Marc J. Baron B.Sc (Hons.), University of Saskatchewan, Saskatoon, SK, Canada, 2008 A thesis presented to Ryerson University

More information

Immunogenicity of Avian Influenza H7N9 Virus in Birds

Immunogenicity of Avian Influenza H7N9 Virus in Birds Immunogenicity of Avian Influenza H7N9 Virus in Birds Identification of Viral Epitopes Recognized by the Immune System Following Vaccination and Challenge Darrell R. Kapczynski US DEPARTMENT OF AGRICULTURE,

More information

Influenza A virus subtype H5N1

Influenza A virus subtype H5N1 Influenza A virus subtype H5N1 Influenza A virus subtype H5N1, also known as A(H5N1) or simply H5N1, is a subtype of the Influenza A virus which can cause illness in humans and many other animal species.

More information

Influenza surveillance and pandemic preparedness - a global challenge Anne Kelso

Influenza surveillance and pandemic preparedness - a global challenge Anne Kelso Influenza surveillance and pandemic preparedness - a global challenge Anne Kelso WHO Collaborating Centre for Reference and Research on Influenza Melbourne, Australia Three global health challenges 243

More information

Role of cyclooxygenase-2 in H5N1 viral pathogenesis and the potential use of its inhibitors

Role of cyclooxygenase-2 in H5N1 viral pathogenesis and the potential use of its inhibitors Title Role of cyclooxygenase-2 in HN viral pathogenesis and the potential use of its inhibitors Author(s) Lee, MY; Cheung, CY; Peiris, JSM Citation Hong Kong Medical Journal, 2, v. 9 n. Suppl. 4, p. 29-

More information

Influenza. Paul K. S. Chan Department of Microbiology The Chinese University of Hong Kong

Influenza. Paul K. S. Chan Department of Microbiology The Chinese University of Hong Kong Influenza Paul K. S. Chan Department of Microbiology The Chinese University of Hong Kong Influenza Virus Nomenclature Influenza virus A, B & C Influenza A : Haemagglutinin (H), neuraminidase (N) A H3N2,

More information

What is influenza virus? 13,000 base RNA genome: 1/ the size of the human genome

What is influenza virus? 13,000 base RNA genome: 1/ the size of the human genome What is influenza virus? 13,000 base RNA genome: 1/246153 the size of the human genome CDC Principles of Virology, 4e Neumann et al. Nature. 2009. Influenza virus is one of the most deadly viral pathogens

More information

Respiratory Syncytial Virus. Respiratory Syncytial Virus. Parainfluenza virus. Acute Respiratory Infections II. Most Important Respiratory Pathogens

Respiratory Syncytial Virus. Respiratory Syncytial Virus. Parainfluenza virus. Acute Respiratory Infections II. Most Important Respiratory Pathogens Acute Respiratory Infections II Most Important Respiratory Pathogens From microbes.historique.net/images An Introduction to One Health Problem Solving PHC 6006 Gregory C. Gray, MD, MPH, FIDSA Professor,

More information

H5N1 avian influenza: timeline

H5N1 avian influenza: timeline H5N1 avian influenza: timeline 28 October 2005 Previous events in Asia 1996 Highly pathogenic H5N1 virus is isolated from a farmed goose in Guangdong Province, China. 1997 Outbreaks of highly pathogenic

More information

SEA/CD/154 Distribution : General. Avian Influenza in South-East Asia Region: Priority Areas for Research

SEA/CD/154 Distribution : General. Avian Influenza in South-East Asia Region: Priority Areas for Research SEA/CD/154 Distribution : General Avian Influenza in South-East Asia Region: Priority Areas for Research World Health Organization Publications of the World Health Organization enjoy copyright protection

More information

Q: If antibody to the NA and HA are protective, why do we continually get epidemics & pandemics of flu?

Q: If antibody to the NA and HA are protective, why do we continually get epidemics & pandemics of flu? Influenza virus Influenza virus Orthomyxoviridae family of viruses RNA enveloped viruses that make up three genera Influenzavirus A Influenzavirus B Influenzavirus C The type A viruses are the most virulent

More information

بسم هللا الرحمن الرحيم

بسم هللا الرحمن الرحيم - 1 - - - 1 P a g e بسم هللا الرحمن الرحيم This sheet was made from record section 1 all information are included - Introduction Our respiratory tract is divided anatomically to upper (URT),middle and

More information

Influenza. Paul K. S. Chan Department of Microbiology The Chinese University of Hong Kong

Influenza. Paul K. S. Chan Department of Microbiology The Chinese University of Hong Kong Influenza Paul K. S. Chan Department of Microbiology The Chinese University of Hong Kong Classification & Nomenclature Influenza virus A, B & C Influenza A : Haemagglutinin (H 1-16), neuraminidase (N1-9)

More information

A Critical Role of Cell Tropism for the Pathogenesis of Influenza

A Critical Role of Cell Tropism for the Pathogenesis of Influenza A Critical Role of Cell Tropism for the Pathogenesis of Influenza Debby van Riel A Critical Role of Cell Tropism for the Pathogenesis of Influenza Thesis, Erasmus University, Rotterdam. With summary in

More information

The A(H7N9) influenza outbreak in China

The A(H7N9) influenza outbreak in China Viruses in May, Katoomba, 9 11 May 2013 The A(H7N9) influenza outbreak in China Anne Kelso Director WHO Collaborating Centre for Reference and Research on Influenza Melbourne Influenza in the 21 st century:

More information

Possible Modes of Transmission of Avian Viruses to People: Studies in Experimental Models

Possible Modes of Transmission of Avian Viruses to People: Studies in Experimental Models Possible Modes of Transmission of Avian Viruses to People: Studies in Experimental Models Jackie Katz and Terry Tumpey Influenza Division CDC, Atlanta, Georgia David E. Swayne USDA/Agricultural Research

More information

Application of Reverse Genetics to Influenza Vaccine Development

Application of Reverse Genetics to Influenza Vaccine Development NIAID Application of Reverse Genetics to Influenza Vaccine Development Kanta Subbarao Laboratory of Infectious Diseases NIAID, NIH Licensed Vaccines for Influenza Principle: Induction of a protective

More information

Trends in influenza A virus genetics: Can we predict the natural evolution of a H5N1 Z?

Trends in influenza A virus genetics: Can we predict the natural evolution of a H5N1 Z? Current Topics in Virology Vol. 7, 2008 Trends in influenza A virus genetics: Can we predict the natural evolution of a H5N1 Z? Earl G. Brown 1, *, Syed A. Sattar 2, Jason A. Tetro 2 and Jinhua Liu 3 1

More information

Cover Page. The handle holds various files of this Leiden University dissertation

Cover Page. The handle   holds various files of this Leiden University dissertation Cover Page The handle http://hdl.handle.net/1887/35908 holds various files of this Leiden University dissertation Author: Soema, Peter Title: Formulation of influenza T cell peptides : in search of a universal

More information

Avian influenza Avian influenza ("bird flu") and the significance of its transmission to humans

Avian influenza Avian influenza (bird flu) and the significance of its transmission to humans 15 January 2004 Avian influenza Avian influenza ("bird flu") and the significance of its transmission to humans The disease in birds: impact and control measures Avian influenza is an infectious disease

More information

Coronaviruses cause acute, mild upper respiratory infection (common cold).

Coronaviruses cause acute, mild upper respiratory infection (common cold). Coronaviruses David A. J. Tyrrell Steven H. Myint GENERAL CONCEPTS Clinical Presentation Coronaviruses cause acute, mild upper respiratory infection (common cold). Structure Spherical or pleomorphic enveloped

More information

Influenza A 6/23/2010. Lisa Winston, MD UCSF / San Francisco General Hospital Divisions of Infectious Diseases and Hospital Medicine

Influenza A 6/23/2010. Lisa Winston, MD UCSF / San Francisco General Hospital Divisions of Infectious Diseases and Hospital Medicine Influenza Update in a Pandemic Year Nothing to disclose. Lisa Winston, MD UCSF / San Francisco General Hospital Divisions of Infectious Diseases and Hospital Medicine Influenza Biology Influenza Biology

More information

Patterns of hemagglutinin evolution and the epidemiology of influenza

Patterns of hemagglutinin evolution and the epidemiology of influenza 2 8 US Annual Mortality Rate All causes Infectious Disease Patterns of hemagglutinin evolution and the epidemiology of influenza DIMACS Working Group on Genetics and Evolution of Pathogens, 25 Nov 3 Deaths

More information

2009 H1N1 Influenza ( Swine Flu ) Hemagglutinin ELISA kit

2009 H1N1 Influenza ( Swine Flu ) Hemagglutinin ELISA kit 2009 H1N1 Influenza ( Swine Flu ) Hemagglutinin ELISA kit Catalog Number : SEK001 To achieve the best assay results, this manual must be read carefully before using this product and the assay is run as

More information

Influenza A virus induced bacterial otitis media is independent of virus tropism for α2,6-linked sialic acid. Short et al.

Influenza A virus induced bacterial otitis media is independent of virus tropism for α2,6-linked sialic acid. Short et al. Influenza A virus induced bacterial otitis media is independent of virus tropism for α2,6-linked sialic acid Short et al. Short et al. Virology Journal 213, 1:128 Short et al. Virology Journal 213, 1:128

More information

ECMO and the 2013 Influenza A H1N1 Epidemic

ECMO and the 2013 Influenza A H1N1 Epidemic ECMO and the 2013 Influenza A H1N1 Epidemic Jonathan Kozinn, MD Department of Cardiac Anesthesiology and Critical Care Why Is an Anesthesiologist Talking About the flu? In susceptible individuals, influenza

More information

Influenza Virus Genotypes Circulating In Central Greece During And Vaccine Strain Match

Influenza Virus Genotypes Circulating In Central Greece During And Vaccine Strain Match ISPUB.COM The Internet Journal of Microbiology Volume 13 Number 1 Influenza Virus Genotypes Circulating In Central Greece During 2012-2014 And Vaccine Strain Match E Plakokefalos, A Vontas, Z Florou, G

More information

Supplementary Figure 1 Weight and body temperature of ferrets inoculated with

Supplementary Figure 1 Weight and body temperature of ferrets inoculated with Supplementary Figure 1 Weight and body temperature of ferrets inoculated with A/Anhui/1/2013 (H7N9) influenza virus. (a) Body temperature and (b) weight change of ferrets after intranasal inoculation with

More information

Equine influenza at the human animal interface Ann Cullinane Irish Equine Centre

Equine influenza at the human animal interface Ann Cullinane Irish Equine Centre Equine influenza at the human animal interface Ann Cullinane Irish Equine Centre Interspecies transmission of H3N8 equine viruses Dogs racing greyhounds in Florida >95% sequence homology with recent equine

More information

Min Levine, Ph. D. Influenza Division US Centers for Disease Control and Prevention. June 18, 2015 NIBSC

Min Levine, Ph. D. Influenza Division US Centers for Disease Control and Prevention. June 18, 2015 NIBSC Workshop on Immunoassay Standardization for Universal Flu Vaccines Min Levine, Ph. D. Influenza Division US Centers for Disease Control and Prevention June 18, 2015 NIBSC 1 Multiple Immune Mechanisms Contribute

More information

Glycan receptor specificity as a useful tool for characterization and surveillance of influenza A virus

Glycan receptor specificity as a useful tool for characterization and surveillance of influenza A virus Glycan receptor specificity as a useful tool for characterization and surveillance of influenza A virus The MIT Faculty has made this article openly available. Please share how this access benefits you.

More information

Human Influenza. Dr. Sina Soleimani. Human Viral Vaccine Quality Control 89/2/29. November 2, 2011 HVVQC ١

Human Influenza. Dr. Sina Soleimani. Human Viral Vaccine Quality Control 89/2/29. November 2, 2011 HVVQC ١ Human Influenza Dr. Sina Soleimani Human Viral Vaccine Quality Control 89/2/29 November 2, 2011 HVVQC ١ Presentation outline 1. Introduction 2. Virology 3. Classification 4. Hosts 5. Antigenic Specifications

More information

Swine influenza surveillance among pigs in Nan Province

Swine influenza surveillance among pigs in Nan Province Swine influenza surveillance among pigs in Nan Province National Institute of Animal Health Department of Livestock Development Nan province 30 Aug 2011 การเฝ าระว งโรคไข หว ดใหญ ส กรในส กร จ งหว ดน าน

More information

Role of receptor binding specificity in influenza A virus transmission and pathogenesis

Role of receptor binding specificity in influenza A virus transmission and pathogenesis Review Role of receptor binding specificity in influenza A virus transmission and pathogenesis Miranda de Graaf & Ron A M Fouchier * Abstract The recent emergence of a novel avian A/H7N9 influenza virus

More information

Impact of Amino Acid Mutations in PB2, PB1-F2, and NS1 on the Replication and Pathogenicity of Pandemic (H1N1) 2009 Influenza Viruses

Impact of Amino Acid Mutations in PB2, PB1-F2, and NS1 on the Replication and Pathogenicity of Pandemic (H1N1) 2009 Influenza Viruses JOURNAL OF VIROLOGY, May 2011, p. 4596 4601 Vol. 85, No. 9 0022-538X/11/$12.00 doi:10.1128/jvi.00029-11 Copyright 2011, American Society for Microbiology. All Rights Reserved. Impact of Amino Acid Mutations

More information

Palindromes drive the re-assortment in Influenza A

Palindromes drive the re-assortment in Influenza A www.bioinformation.net Hypothesis Volume 7(3) Palindromes drive the re-assortment in Influenza A Abdullah Zubaer 1, 2 * & Simrika Thapa 1, 2 1Swapnojaatra Bioresearch Laboratory, DataSoft Systems, Dhaka-15,

More information

REVIEW Cell-mediated Immunity to Influenza Virus Infections: From the Perspective to the Vaccine Development against Highly Pathogenic Avian Influenza

REVIEW Cell-mediated Immunity to Influenza Virus Infections: From the Perspective to the Vaccine Development against Highly Pathogenic Avian Influenza JARQ 42 (4), 245 249 (2008) http://www.jircas.affrc.go.jp REVIEW : From the Perspective to the Vaccine Development against Highly Pathogenic Avian Influenza Hirokazu HIKONO 1 *, Masaji MASE 2, Satoko WATANABE

More information

Strategies for containing an emerging influenza pandemic in South East Asia 1

Strategies for containing an emerging influenza pandemic in South East Asia 1 Strategies for containing an emerging influenza pandemic in South East Asia 1 Modeling pandemic spread and possible control plans of avian flu H5N1 BBSI, Nicole Kennerly, Shlomo Ta asan 1 Nature. 2005

More information

Influenza A H1N1 (Swine Flu 2009) Hemagglutinin / HA ELISA Pair Set

Influenza A H1N1 (Swine Flu 2009) Hemagglutinin / HA ELISA Pair Set Influenza A H1N1 (Swine Flu 2009) Hemagglutinin / HA ELISA Pair Set Catalog Number : SEK001 To achieve the best assay results, this manual must be read carefully before using this product and the assay

More information

Avian Influenza Viruses with Pandemic Potential

Avian Influenza Viruses with Pandemic Potential Avian Influenza Viruses with Pandemic Potential Takato Odagiri Director WHO Collaborating Center on Influenza, Tokyo and Influenza Virus Research Center, National Institute of Infectious Diseases, Japan

More information

Emergence of distinct avian-like influenza A H1N1 viruses in pigs in Ireland and their reassortment with cocirculating H3N2 viruses

Emergence of distinct avian-like influenza A H1N1 viruses in pigs in Ireland and their reassortment with cocirculating H3N2 viruses International Congress Series 1263 (2004) 209 213 Emergence of distinct avian-like influenza A H1N1 viruses in pigs in Ireland and their reassortment with cocirculating H3N2 viruses Y.P. Lin a, *, M. Bennett

More information

Avian and swine influenza viruses: our current understanding of the zoonotic risk

Avian and swine influenza viruses: our current understanding of the zoonotic risk Vet. Res. 38 (2007) 243 260 243 c INRA, EDP Sciences, 2007 DOI: 10.1051/vetres:2006062 Review article Avian and swine influenza viruses: our current understanding of the zoonotic risk Kristen VAN REETH*

More information

INFLUENZA A VIRUS. Structure of the influenza A virus particle.

INFLUENZA A VIRUS. Structure of the influenza A virus particle. INFLUENZA INFLUENZA A VIRUS Structure of the influenza A virus particle. TYPE A VIRUS HAS TWO TYPES OF SPIKES, THE HEMAGGLUTININ (H) AND THE NEURAMINIDASE (N), PROTRUDING FROM THE VIRAL ENVELOPE THE HEMAGGLUTININ

More information

Segments 7 codes for M1 and M2 proteins (Matrix proteins)

Segments 7 codes for M1 and M2 proteins (Matrix proteins) One Flu over the Cuckoo s nest Dr Rachel Jones Department of Virology NPHS Microbiology Cardiff Whistlestop tour through Flu The virus Some history The Novel Virus Recent events The disease The control

More information

Characterization of the 1918 influenza virus polymerase genes

Characterization of the 1918 influenza virus polymerase genes Vol 437 6 October 2005 doi:10.1038/nature04230 Characterization of the 1918 influenza virus polymerase genes Jeffery K. Taubenberger 1, Ann H. Reid 1, Raina M. Lourens 1, Ruixue Wang 1, Guozhong Jin 1

More information

1918 Influenza; Influenza A, H1N1. Basic agent information. Section I- Infectious Agent. Section II- Dissemination

1918 Influenza; Influenza A, H1N1. Basic agent information. Section I- Infectious Agent. Section II- Dissemination 1918 Influenza; Influenza A, H1N1 Basic agent information Section I- Infectious Agent Risk Group: - RG3 Synonym or Cross reference: - Spanish Flu - 1918 Flu - El Grippe Characteristics: - SELECT AGENT

More information

Ralph KY Lee Honorary Secretary HKIOEH

Ralph KY Lee Honorary Secretary HKIOEH HKIOEH Round Table: Updates on Human Swine Influenza Facts and Strategies on Disease Control & Prevention in Occupational Hygiene Perspectives 9 July 2009 Ralph KY Lee Honorary Secretary HKIOEH 1 Influenza

More information

Phylogenetic Methods

Phylogenetic Methods Phylogenetic Methods Multiple Sequence lignment Pairwise distance matrix lustering algorithms: NJ, UPM - guide trees Phylogenetic trees Nucleotide vs. amino acid sequences for phylogenies ) Nucleotides:

More information

Lecture 11. Immunology and disease: parasite antigenic diversity

Lecture 11. Immunology and disease: parasite antigenic diversity Lecture 11 Immunology and disease: parasite antigenic diversity RNAi interference video and tutorial (you are responsible for this material, so check it out.) http://www.pbs.org/wgbh/nova/sciencenow/3210/02.html

More information

Hemagglutinin protein of Asian strains of human influenza virus A H1N1 binds to sialic acid - a major component of human airway receptors

Hemagglutinin protein of Asian strains of human influenza virus A H1N1 binds to sialic acid - a major component of human airway receptors Hemagglutinin protein of Asian strains of human influenza virus A H1N1 binds to sialic acid - a major component of human airway receptors K.H. Chua 1 and H.C. Chai 2 1 Department of Molecular Medicine,

More information

Nanoparticulate Vaccine Design: The VesiVax System

Nanoparticulate Vaccine Design: The VesiVax System Nanoparticulate Vaccine Design: The VesiVax System Gary Fujii, Ph.D. President and CEO Molecular Express, Inc. May 16, 2006 Orlando, Florida Influenza Each year up to 20% of the world's population contracts

More information

Origins and evolutionary genomics of the novel avian-origin H7N9 influenza A virus in China: Early findings

Origins and evolutionary genomics of the novel avian-origin H7N9 influenza A virus in China: Early findings Origins and evolutionary genomics of the novel 2013 avian-origin H7N9 influenza A virus in : Early findings Jiankui He*, Luwen Ning, Yin Tong Department of Biology, South University of Science and Technology

More information

Cloudbreak. January Cidara Therapeutics

Cloudbreak. January Cidara Therapeutics Cloudbreak January 2019 Cidara Therapeutics 2019 0 Forward-Looking Statements These slides and the accompanying oral presentation contain forward-looking statements within the meaning of the Private Securities

More information

Lipid raft-a gateway for passing through the cell membrane for pathogens

Lipid raft-a gateway for passing through the cell membrane for pathogens 16 3 2004 6 Chinese Bulletin of Life Sciences Vol. 16, No. 3 Jun., 2004 10040374(2004)03014404 200031 / GPI (GPI) Q241 Q257 R37 A Lipid rafta gateway for passing through the cell membrane for pathogens

More information

Supporting Information

Supporting Information Supporting Information Yen et al. 10.1073/pnas.1111000108 SI Materials and Methods Cells. Madin Darby canine kidney (MDCK) cells and human embryonic kidney 293T cells were obtained from the American Type

More information

Emergence and Fixing of Antiviral Resistance in Influenza A Via Recombination and Hitch Hiking. Henry L Niman

Emergence and Fixing of Antiviral Resistance in Influenza A Via Recombination and Hitch Hiking. Henry L Niman Emergence and Fixing of Antiviral Resistance in Influenza A Via Recombination and Hitch Hiking Henry L Niman Recombinomics, Inc, Pittsburgh, Pennsylvania USA Department of Influenza Recombination Recombinomics,

More information